Cost-effectiveness of albumin in the treatment of decompensated cirrhosis in resource-limited healthcare settings
This study aims to assess the cost-effectiveness of human albumin in patients with cirrhosis with spontaneous bacterial peritonitis, hepatorenal syndrome or ascites requiring large-volume paracentesis in the Indonesian healthcare system as a representative of a resource-limited setting.